ClinConnect ClinConnect Logo
Search / Trial NCT00001325

Metabolic Abnormalities in Children With Epilepsy

Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Nov 3, 1999

Trial Information

Current as of March 21, 2025

Completed

Keywords

Positron Tomography Seizures Epileptic Focus Electroencephalography Metabolism Glucose Cerebral Positron Emission Tomography Lennox Gastaut Syndrome

ClinConnect Summary

We propose to study children with recent onset partial epilepsy, cryptogenic infantile spasms, and idiopathic Lennox-Gastaut Syndrome with serial FDG-PET to elucidate the natural history and evolution of metabolic abnormalities associated with such epilepsies. The severity of the seizure disorder, and cognitive impairment, when present, will be correlated with the presence and extent of focal and global cerebral metabolic abnormalities.

Gender

ALL

Eligibility criteria

  • INCLUSION CRITERIA:
  • Patients with partial seizures, infantile spasms and Lennox-Gastaut syndrome will be selected.
  • EXCLUSION CRITERIA:
  • Evidence of a structural lesion as cause for epilepsy.
  • Degenerative or metabolic disease.
  • Inability to comply with the protocol.

About National Institute Of Neurological Disorders And Stroke (Ninds)

The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.

Locations

Bethesda, Maryland, United States

People applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials